Leprosy: an epidemiological view in the Brazilian regions in recent years
DOI:
https://doi.org/10.36557/2674-8169.2024v6n4p647-656Keywords:
Epidemiologia, Hanseníase, Lepra, Saúde coletiva.Abstract
This study investigated the incidence of leprosy in Brazilian regions in the time between 2019 and 2023. Leprosy is a chronic granulomatous infection, also known as leprosy. Leprosy is an infectious disease that causes pathology that affects the skin with characteristic lesions, peripheral nervous system (PNS) and internal organs, this caused by the bacterium Mycobacterium leprae. The objective of this study was to evaluate the incidence of leprosy cases in the Brazilian population in the last 5 years. Thus, it will be possible to form public health policies and interventions aimed at the prevention and control of health related to leprosy in all regions of Brazil. This is a descriptive epidemiological study. Data from the Notifiable Diseases Information System of the Brazilian Ministry of Health (DATASUS) were analyzed. Bibliographic research was used as an instrument, using MEDLINE, PUBMED, LILACS and SciELO as databases. The selected participants were adult male and female patients from all regions of Brazil, from 2019 to 2023. Reports of the year of diagnosis and registration for leprosy were prepared, considering variables such as the region where the test was performed, age group, and leprosy diagnoses. Analysis of the frequency of leprosy diagnoses in Brazil between 2019 and 2023 indicates a general trend of decline in the number of cases after 2019. However, it is still crucial to maintain ongoing efforts to raise awareness, early detection, and access health services.
Downloads
References
ARAÚJO, M. G. Hanseníase no Brasil. Revista da Sociedade Brasileira de Medicina Tropical 36(3):373-382, mai-jun, 2003.
BLUTEAU, D. Raphael. Vocabulário português e latino. v.7. Lisboa: Paschoal da Silva. 1720.
GOULART, I. M. B.; et al. Imunopatologia da hanseníase: a complexidade dos mecanismos da resposta imune do hospedeiro ao Mycobacterium leprae. Revista da Sociedade Brasileira de Medicina Tropical 35(4): 365-375, jul-ago, 2002.n.
INCA - Instituto Nacional de Câncer. Resolução CNS 466/12. Disponível em: https://www.inca.gov.br/publicacoes/legislacao/resolucao-cns-466-12. Acesso em 29 de novembro de 2023.
MENDONÇA, V. A.; et al. Imunologia da hanseníase. An Bras Dermatol. 2008;83(4):343-50. Disponível em: https://www.scielo.br/j/abd/a/tLJZgCGdYrsP5kwZQqKVP9s/ Acesso em 29 de novembro de 2023.
Ministério da Saúde. Sistema de Informação de Agravos de Notificação - Sinan Net do Departamento de Informática do Sistema Único de Saúde (DATASUS). Disponível em: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinannet/cnv/hanswbr.def. Acesso em 15 de novembro de 2023.
STEINMANN P.; et al. O impacto a longo prazo do programa de Profilaxia Pós-Exposição da Hanseníase (LPEP) na incidência da hanseníase: um estudo de modelagem. PLoS Negl Trop Dis. 2021;15(3):e0009279. doi: 10.1371/journal.pntd.000927
PEDRO, H. da S. P.; et al. Hanseníase e laboratório: uma interação desafiadora. BEPA 2014;11(126):1-14. Disponível em: https://periodicos.saude.sp.gov.br/BEPA182/article/view/38223 Acesso em 25 de novembro de 2023.
ZAMPARONI, Valdemir. Lepra: doença, isolamento e segregação no contexto colonial em Moçambique. História, Ciências, Saúde – Manguinhos, Rio de Janeiro, v.24, n.1, jan.-mar. 2017, p.13- 39. Disponível em: scielo.br/j/hcsm/a/85mKFdZS89CRYZMCr75p3NK/?format=pdf Acesso em 29 de novembro de 2023.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Lucas Santos Sousa, Soraya Martins Mendes Vieira, Evile Cristina Silva Rabelo, Janessa Moura dos Santos, Ana Lícia Araújo da Silva, Gabriella da Silva Barros, Isabella Ferreira Nascimento, Geovana Ponciano Mendonça , Fabiana de Morais, Anísia Ferreira de Lima , Larissa da Fonseca Guimarães , Tercília Maria Sousa Soares, Erick Silva Freire , Rosane Cristina Mendes Gonçalves, Marcos Antônio Silva Batista
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.
